Changes in prescription patterns betwwen two medication classes sodium-glucose cotransporter 2 inhibitors (SGLT2i) and glucagon-like peptide 1 receptor agonists (GLP-1RA)
Latest Information Update: 20 Feb 2020
At a glance
- Drugs Albiglutide (Primary) ; Canagliflozin (Primary) ; Dapagliflozin (Primary) ; Dulaglutide (Primary) ; Empagliflozin (Primary) ; Exenatide (Primary) ; Liraglutide (Primary) ; Semaglutide (Primary)
- Indications Type 1 diabetes mellitus; Type 2 diabetes mellitus
- Focus Therapeutic Use
Most Recent Events
- 20 Feb 2020 New trial record
- 10 Feb 2020 Results published in the Diabetes Care.